Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Persistence of Telemedicine Usage for Breast and Prostate Cancer after the Peak of the COVID-19 Pandemic.
Cancers (Basel). 2023 Oct 12;15(20):4961. doi: 10.3390/cancers15204961.
Cancers (Basel). 2023.
PMID: 37894328
Free PMC article.
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer.
Mitchell AP, Nemirovsky D, Mishra Meza A, Chakraborty N, Persaud S, Farooki A, Morris MJ.
Mitchell AP, et al. Among authors: chakraborty n.
JCO Oncol Pract. 2024 Mar;20(3):393-400. doi: 10.1200/OP.23.00602. Epub 2024 Jan 8.
JCO Oncol Pract. 2024.
PMID: 38190588
Item in Clipboard
Cite
Cite